Cadila Healthcare’s Stock Tumbles After U.S. FDA Issues Warning Letter For Largest Unit
Brightly coloured pharmaceutical medication, including antibiotics, paracetamol, Ibuprofen and cold relief tablets in the U.K. (Photographer: Chris Ratcliffe/Bloomberg)

Cadila Healthcare’s Stock Tumbles After U.S. FDA Issues Warning Letter For Largest Unit

Shares of Cadila Healthcare Ltd. dropped the most in more than a year after the U.S. drug regulator issued a warning letter for its manufacturing unit at Moraiya, Gujarat, barring fresh approvals f...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.